Participants
180 male patients with a histologically proven diagnosis of prostate
adenocarcinoma were included in the study, and those with a previous
diagnosis of cancer in another body part were excluded. Individuals with
either the usual digital rectal examination or remarkable digital rectal
examination findings but benign prostatic hyperplasia (BPH) which is
histologically confirmed without malignancy were included in the control
group. The control group consisted of 240 male individuals whose ages
were the same as the patients.